Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
|
Year |
Age range all adults |
Sample size all adults |
All |
All females (%) |
Total (%) |
Age range young adults |
Sample size young adults |
Young males (%) |
Young females (%) |
Total (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Belgium |
|
2001 |
15-64 |
7347 |
3.6 |
1.8 |
2.7 |
15-34 |
2758 |
8.9 |
3.1 |
5.9 |
Denmark |
|
2000 |
16-64 |
11825 |
4.5 |
1.3 |
2.8 |
16-34 |
4141 |
9.1 |
2.6 |
5.6 |
Germany |
|
2003 |
18-59 |
8061 |
4.7 |
2.1 |
3.4 |
18-34 |
3775 |
9.9 |
5.2 |
7.6 |
Estonia |
|
2003 |
|
|
2.4 |
0.6 |
1.4 |
|
646 |
5.6 |
1.4 |
3.3 |
Greece |
|
2004 |
15-64 |
4351 |
1.3 |
0.4 |
0.9 |
15-34 |
2620 |
2.1 |
0.9 |
1.5 |
Spain |
|
2001 |
15-64 |
14113 |
9.8 |
3.7 |
6.8 |
15-34 |
6915 |
16.4 |
7.2 |
11.9 |
France |
(1) |
2000 |
15-64 |
11317 |
6.3 |
2.5 |
4.4 |
15-34 |
4749 |
13.2 |
5.3 |
9.3 |
Ireland |
|
2002/03 |
15-64 |
4925 |
3.4 |
1.7 |
2.6 |
15-34 |
|
5.7 |
3.0 |
4.4 |
Italy |
|
2003 |
15-64 |
11869 |
6.2 |
3.3 |
4.6 |
15-34 |
5231 |
10.9 |
6.7 |
8.6 |
Cyprus |
(2) |
2003 |
15-65 |
1000 |
18.1 |
0.0 |
9.0 |
15-34 |
580 |
23.3 |
0.0 |
12.8 |
Latvia |
|
2003 |
15-64 |
|
3.1 |
0.8 |
1.8 |
15-34 |
|
5.9 |
1.7 |
3.7 |
Hungary |
|
2003 |
18-54 |
|
1.9 |
0.8 |
1.4 |
18-34 |
2319 |
3.8 |
1.6 |
2.8 |
Netherlands |
|
2000/01 |
15-64 |
14045 |
5.1 |
2.2 |
3.7 |
15-34 |
6687 |
9.7 |
4.2 |
7.0 |
Poland |
|
2002 |
16-64 |
|
2.0 |
0.6 |
1.3 |
16-34 |
|
4.1 |
1.1 |
2.7 |
Portugal |
|
2001 |
15-64 |
14184 |
4.1 |
0.7 |
2.4 |
15-34 |
6406 |
7.4 |
1.4 |
4.4 |
Slovakia |
|
2002 |
18-64 |
1405 |
4.0 |
1.5 |
2.7 |
18-34 |
|
8.3 |
3.3 |
5.9 |
Finland |
(3) |
2002 |
15-64 |
2377 |
1.6 |
0.7 |
1.1 |
15-34 |
1240 |
3.8 |
1.9 |
2.9 |
Sweden |
|
2004 |
18-64 |
9514 |
1.2 |
0.3 |
0.8 |
18-34 |
2985 |
2.5 |
0.7 |
1.6 |
United Kingdom (E & W) |
|
2003/04 |
16-59 |
24422 |
8.7 |
4.3 |
6.5 |
16-34 |
8590 |
15.8 |
8.1 |
12 |
Notes: (1) France: the 2000 surveys was used, instead of the more recent 2002 survey, as this last one did not have information on 'last month prevalence'. (2) Results of this survey should be viewed with caution due to important discrepancies with previous surveys and school surveys results. A new survey with a bigger sample is being conducted in 2005. (3) Finland: Further information on frequency of use in last 30 days collected but not reported due to low numbers of users. For methods and definitions on population surveys in general, see [Methods and definitions - prevalence and patterns of drug use in the general population]. For methods of each survey presented in this table, see [Table GPS-1 part (ii)]. Sources: See [Table GPS-0] | ||||||||||||